TYRA BIOSCIENCES INC's ticker is and the CUSIP is 90240B106. A total of 49 filers reported holding TYRA BIOSCIENCES INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $4,330,899 | -12.3% | 314,478 | +8.4% | 0.00% | 0.0% |
Q2 2023 | $4,938,665 | +7.4% | 289,998 | +1.4% | 0.00% | 0.0% |
Q1 2023 | $4,597,691 | +238369.5% | 286,104 | +12.8% | 0.00% | – |
Q4 2022 | $1,928 | -99.9% | 253,692 | +2.5% | 0.00% | – |
Q3 2022 | $2,175,000 | +35.0% | 247,450 | +9.8% | 0.00% | – |
Q2 2022 | $1,611,000 | -28.5% | 225,411 | +7.1% | 0.00% | – |
Q1 2022 | $2,252,000 | -22.4% | 210,549 | +2.0% | 0.00% | – |
Q4 2021 | $2,903,000 | – | 206,381 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Canaan Partners XI LLC | 4,409,991 | $47,187,000 | 19.65% |
Nextech Invest Ltd. | 2,518,582 | $26,949,000 | 7.69% |
TCG Crossover Management, LLC | 896,418 | $9,592,000 | 3.85% |
Boxer Capital, LLC | 6,448,359 | $68,997,000 | 3.55% |
Fairmount Funds Management LLC | 1,284,990 | $13,749,000 | 3.25% |
RA Capital Management | 7,236,454 | $77,430,000 | 1.69% |
Frazier Life Sciences Management, L.P. | 1,327,665 | $14,206,000 | 1.21% |
BVF INC/IL | 2,472,327 | $26,454,000 | 1.06% |
Cormorant Asset Management, LP | 757,432 | $8,105,000 | 0.62% |
Sio Capital Management, LLC | 111,033 | $1,188,000 | 0.39% |